Alarming Antibiotic Resistance in Pediatric Oncology Patients: A Three-Year Prospective Cohort Study from Oman.

Al Battashi, Abeer; Al Harrassi, Bishara; Al Maskari, Nawal; Al Hashami, Hilal; Al Awaidy, Salah

Al Battashi, Abeer; Al Harrassi, Bishara; Al Maskari, Nawal; Al Hashami, Hilal; Al Awaidy, Salah.

Afiliación

Al Battashi A; Department of Pediatric Hematology and Oncology, The National Oncology Centre, Royal Hospital, Ministry of Health, Muscat, Oman.
Al Harrassi B; Oman Medical Specialty Board, Muscat, Oman.
Al Maskari N; Pediatric Infectious Diseases, Child Health Department, Royal Hospital, Ministry of Health, Muscat, Oman.
Al Hashami H; Pediatric Infectious Diseases, Child Health Department, Royal Hospital, Ministry of Health, Muscat, Oman.
Al Awaidy S; Office of Health Affairs, Ministry of Health, Muscat, Oman.

Infect Drug Resist ; 15: 3939-3947, 2022.

Article en En | MEDLINE | ID: mdl-35915810

Palabras clave

Oman; antibiotic susceptibility; bloodstream infections; neutropenia; pediatric oncology

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Infect Drug Resist Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google